Business Context and Reporting Period
This Form 6-K filing by Amdocs Limited reports the results of the 2026 Annual General Meeting of Shareholders held on January 30, 2026. The filing details the voting outcomes for five specific proposals submitted to shareholders.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document focuses exclusively on corporate governance voting results rather than financial performance data.
Material Changes and Voting Results
Shareholders approved all five proposals presented at the meeting. Key outcomes include:
- Board Election: All ten nominees were elected to the Board of Directors for one-year terms. Notably, Robert A. Minicucci received the highest number of "Against" votes (14,069,326) compared to other nominees, though he was still elected.
- Dividend Increase: The quarterly cash dividend rate was approved to increase from $0.527 per share to $0.569 per share.
- Employee Plan Amendment: Shareholders approved an amendment to the 2023 Employee Share Purchase Plan to increase the number of reserved ordinary shares by 2,200,000.
- Financial Statements: The Consolidated Financial Statements for the fiscal year ended September 30, 2025, were approved.
- Auditor Ratification: Ernst & Young LLP was ratified as the independent registered public accounting firm for the fiscal year ending September 30, 2026.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, forward-looking guidance, risk factors, or contingencies. The document is a procedural report of shareholder voting results.
Investor Verification Checklist
- Verify the implementation timeline for the increased quarterly dividend rate of $0.569 per share.
- Review the full 2026 Proxy Statement for detailed biographies of the newly elected directors and the rationale behind the significant "Against" votes for Robert A. Minicucci.
- Confirm the impact of the 2,200,000 share increase on the Employee Share Purchase Plan dilution.
- Locate the full Consolidated Financial Statements for the fiscal year ended September 30, 2025, which were ratified but not included in this filing.